<DOC>
	<DOCNO>NCT02558127</DOCNO>
	<brief_summary>The combination asthma carrier genetic variant ( mutation / polymorphism ) CFTR gene variant would cause bronchial asthma mucus hypersecretion . This phenotype characterize severe disease , term control , quality life , exacerbation lung function , different asthma bronchial hypersecretion without inflammatory phenotype .</brief_summary>
	<brief_title>Asthma With Hypersecretion-associated Gene Cystic Fibrosis</brief_title>
	<detailed_description>Primary objective : Determine presence genetic variant ( mutation / polymorphism ) CFTR gene patient asthma without bronchial mucus hypersecretion . Secondary objective : To identify genetic variant ( mutation / polymorphism ) common CFTR gene asthmatic population . -To define inflammatory phenotype asthma bronchial mucus hypersecretion . -To compare severity , control , quality life frequency exacerbation asthma patient without bronchial mucus hypersecretion</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Inclusion criterion : Asthmatic patient age 18 80 years.They respiratory infection last month . Criteria exclusion : Presence lung disease , Sequelae tuberculosis , Bronchiectasis ( large , secondary different asthma respiratory disease ) , Cystic fibrosis , Residual pleural disease , Interstitial diseases , Severe comorbidity , Patients oral corticosteroid immunomodulators cause asthma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>asthma</keyword>
	<keyword>cystic fibrosis</keyword>
</DOC>